
TY  - JOUR
TI  - REVIEW OF CURRENT LITERATURE
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
VL  - 58
IS  - 1
SN  - 1470-0328
UR  - https://doi.org/10.1111/j.1471-0528.1951.tb04899.x
DO  - doi:10.1111/j.1471-0528.1951.tb04899.x
SP  - 109
EP  - 164
PY  - 1951
ER  - 

TY  - JOUR
TI  - American Society for Laser Medicine and Surgery Abstracts
JO  - Lasers in Surgery and Medicine
JA  - Lasers Surg. Med.
VL  - 48
IS  - S27
SN  - 0196-8092
UR  - https://doi.org/10.1002/lsm.22485
DO  - doi:10.1002/lsm.22485
SP  - 1
EP  - 92
PY  - 2016
ER  - 

TY  - JOUR
TI  - Moderated Poster Presentations
JO  - International Journal of Urology
VL  - 13
IS  - s1
SN  - 0919-8172
UR  - https://doi.org/10.1111/j.1442-2042.2006.01622.x
DO  - doi:10.1111/j.1442-2042.2006.01622.x
SP  - A23
EP  - A62
PY  - 2006
ER  - 

TY  - JOUR
TI  - OTHER NEUROLOGICAL DISEASES
JO  - Developmental Medicine & Child Neurology
VL  - 12
IS  - s21
SN  - 0012-1622
UR  - https://doi.org/10.1111/j.1469-8749.1970.tb02405.x
DO  - doi:10.1111/j.1469-8749.1970.tb02405.x
SP  - 63
EP  - 71
PY  - 1970
ER  - 

TY  - JOUR
AU  - Amrith, Sunil S.
TI  - Currents of Global Migration
JO  - Development and Change
JA  - Development and Change
VL  - 45
IS  - 5
SN  - 0012-155X
UR  - https://doi.org/10.1111/dech.12109
DO  - doi:10.1111/dech.12109
SP  - 1134
EP  - 1154
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 25
IS  - S1
SN  - 1351-5101
UR  - https://doi.org/10.1111/ene.13635
DO  - doi:10.1111/ene.13635
SP  - 1
EP  - 65
PY  - 2018
ER  - 

TY  - JOUR
AU  - Chamney, Anne R.
TI  - Humidification requirements and techniques
JO  - Anaesthesia
VL  - 24
IS  - 4
SN  - 0003-2409
UR  - https://doi.org/10.1111/j.1365-2044.1969.tb02914.x
DO  - doi:10.1111/j.1365-2044.1969.tb02914.x
SP  - 602
EP  - 617
PY  - 1969
ER  - 

TY  - JOUR
TI  - ESSR ABSTRACTS 2010
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S4
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.7159
DO  - doi:10.1002/bjs.7159
SP  - S59
EP  - S121
PY  - 2010
AB  - Abstract The 45th Congress of the European Society for Surgical Research takes place this year in Geneva, Switzerland, 9?12 June 2010, under the presidency of Mustafa Cikirikcioglu, MD, PhD. Copyright ? 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Contents
JO  - Alzheimer's & Dementia
JA  - Alzheimer's & Dementia
VL  - 10
IS  - 4S_Part_1
SN  - 1552-5260
UR  - https://doi.org/10.1016/S1552-5260(14)02772-1
DO  - doi:10.1016/S1552-5260(14)02772-1
SP  - A1
EP  - A4
PY  - 2014
ER  - 

TY  - JOUR
AU  - Goel, Ruchika
AU  - Johnson, Daniel J.
AU  - Scott, Andrew V.
AU  - Tobian, Aaron A.R.
AU  - Ness, Paul M.
AU  - Nagababu, Enika
AU  - Frank, Steven M.
TI  - Red blood cells stored 35 days or more are associated with adverse outcomes in high-risk patients
JO  - Transfusion
JA  - Transfusion
VL  - 56
IS  - 7
SN  - 0041-1132
UR  - https://doi.org/10.1111/trf.13559
DO  - doi:10.1111/trf.13559
SP  - 1690
EP  - 1698
PY  - 2016
AB  - BACKGROUND Clinical trials have shown that longer red blood cell (RBC) storage duration does not worsen outcomes; however, these studies included few RBCs near the end of the 42-day storage limit. We tested the hypothesis that these ?oldest? RBCs are associated with adverse outcomes. STUDY DESIGN AND METHODS In a retrospective study, 28,247 transfused patients given 129,483 RBC units were assessed. Morbidity, mortality, and length of stay (LOS) were compared in patients transfused exclusively with RBCs stored not more than 21 days versus patients transfused exclusively with RBCs stored 28 days or more and patients transfused exclusively with RBCs stored 35 days or more. RESULTS After risk adjustment, ≥35-day RBCs were associated with increased morbidity (adjusted odds ratio [adjOR], 1.19; 95% confidence interval [CI], 1.07-1.32; p = 0.002), but ≥28-day RBCs were not (adjOR, 1.06; 95% CI, 0.97-1.15; p = 0.2). Neither ≥35-day nor ≥28-day RBCs were associated with increased mortality. In critically ill patients, ≥35-day RBCs were associated with increased morbidity (adjOR, 1.25; 95% CI, 1.08-1.44; p = 0.002) and mortality (adjOR, 1.38; 95% CI, 1.08-1.74; p = 0.009), but ≥28-day RBCs were associated with neither. In older patients, ≥35-day RBCs were associated with increased morbidity (adjOR, 1.22; 95% CI, 1.04-1.42; p = 0.01), but not mortality (adjOR, 1.28; 95% CI, 0.96-1.71; p = 0.1), and ≥28-day RBCs were associated with neither. LOS was increased for both ≥28- and ≥35-day RBCs for all patients and the critically ill and older subgroups. CONCLUSIONS RBCs transfused in the last 7 days of their 42-day storage limit may be associated with adverse clinical outcomes in high-risk patients.
ER  - 

AU  - Ahn, Samuel S.
AU  - Huang, Carber C.
AU  - Hays, Foster A.
C7  - pp. 280-300
TI  - Stents for Peripheral Arteries and Veins
SN  - 9781444330717
UR  - https://doi.org/10.1002/9781118481370.ch19
DO  - doi:10.1002/9781118481370.ch19
SP  - 280-300
KW  - stents, for peripheral arteries and veins
KW  - vascular stents, intraluminal mechanical scaffolds opposing elastic recoil
KW  - vascular stents, thermal-expanding, the Strecker stent of tantalum wire mesh
KW  - Palmaz stent, balloon-expandable, labeling system unique to stent
KW  - drug-eluting stents in infrapopliteal, for Ruthford category 4 through 6
KW  - thermal-expanding stents, special class of self-expanding stents
KW  - intravascular stent placement, and biologic response
KW  - tissue–stent dynamics, by size, composition, stent design
KW  - stent placement indications
KW  - stent placement, and relative contraindications
PY  - 2016
AB  - Summary This chapter contains sections titled: General principles of vascular stents Biologic response to intravascular stent placement Indications for stent placement Relative contraindications to stent placement Complications Stents in iliac arteries Stents in femoropopliteal arteries Infrapopliteal stents Stents in peripheral veins Future stents Summary References
ER  - 

TY  - JOUR
AU  - Nave, Klaus
TI  - Plenary Talk P03: Axon–glia interactions and the control of myelination
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_1.x
DO  - doi:10.1111/j.1474-1644.2005.03230_1.x
SP  - 69
EP  - 69
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW03: Glia and inflammation II
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_10.x
DO  - doi:10.1111/j.1474-1644.2005.03230_10.x
SP  - 88
EP  - 91
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW05: Ischemia
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_12.x
DO  - doi:10.1111/j.1474-1644.2005.03230_12.x
SP  - 95
EP  - 98
PY  - 2005
ER  - 

TY  - JOUR
AU  - Chandross, K.
AU  - Merrill, J.
TI  - Colloquium C11: Lipid pathways as targets for MS therapy
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_7.x
DO  - doi:10.1111/j.1474-1644.2005.03230_7.x
SP  - 79
EP  - 80
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW02: Gene expression and signaling II
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_9.x
DO  - doi:10.1111/j.1474-1644.2005.03230_9.x
SP  - 85
EP  - 87
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster session PTW06: Parkinson's and other diseases
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_13.x
DO  - doi:10.1111/j.1474-1644.2005.03230_13.x
SP  - 99
EP  - 103
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW07: Demyelination
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_14.x
DO  - doi:10.1111/j.1474-1644.2005.03230_14.x
SP  - 104
EP  - 108
PY  - 2005
ER  - 

TY  - JOUR
AU  - Haydon, P.
TI  - Symposium S06: Astrocytic regulation of neuronal excitability and synaptic transmission
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_3.x
DO  - doi:10.1111/j.1474-1644.2005.03230_3.x
SP  - 72
EP  - 72
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session PTW04: Axon growth and cytoskeleton
JO  - Journal of Neurochemistry
VL  - 94
IS  - s1
SN  - 9781444330717
UR  - https://doi.org/10.1111/j.1474-1644.2005.03230_11.x
DO  - doi:10.1111/j.1474-1644.2005.03230_11.x
SP  - 92
EP  - 94
PY  - 2005
ER  - 
